SCHEMBL3973609

SCHEMBL3973609

NC(=O)c1ccc(-c2ccccc2)c(OCCCCl)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 2/20 0.47
MKNK2 Q9HBH9 1/20 0.47
EGFR P00533 1/20 0.46
LMNA P02545 1/20 0.45
CYP11B1 P15538 2/20 0.45
CYP11B2 P19099 2/20 0.45
PDE4A P27815 1/20 0.44
PDE4B Q07343 1/20 0.44
PDE4C Q08493 1/20 0.44
PDE4D Q08499 1/20 0.44
PARP10 Q53GL7 1/20 0.44
CHEK2 O96017 1/20 0.43
KDM4E B2RXH2 3/20 0.42
RXRA P19793 1/20 0.42
RXRB P28702 1/20 0.42
RXRG P48443 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
ROCK2 O75116 1/20 0.41
ROCK1 Q13464 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3973587 0.96 MKNK1 (0.48) MKNK1MKNK2EGFRLMNACYP11B1
SCHEMBL3972289 0.88 MKNK1 (0.46) MKNK1MKNK2EGFRLMNACYP11B1
SCHEMBL3974889 0.86 MKNK1 (0.47) MKNK1MKNK2EGFRLMNACYP11B1
SCHEMBL9306503 0.85 THRA (0.56) MKNK1MKNK2LMNAPDE4APDE4B
SCHEMBL5227439 0.82 RXRA (0.59) CYP11B1CYP11B2PARP10KDM4ERXRA
SCHEMBL3975202 0.80 PARP10 (0.42) MKNK1MKNK2PDE4DPARP10L3MBTL1
SCHEMBL31696706 0.79 EGFR (0.53) EGFRLMNACYP11B1CYP11B2PDE4A
SCHEMBL2967356 0.78 MKNK1 (0.72) MKNK1MKNK2EGFRLMNAPDE4A
Methane SCHEMBL21358430 0.77 MKNK1 (0.70) MKNK1MKNK2EGFRLMNAPDE4A
SCHEMBL8747413 0.76 EGFR (0.64) EGFRCYP11B1CYP11B2PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2054383-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS SmithKline Beecham Corporation (US) 2009-05-06 EP disclosed
WO-2008021849-A2 NOVEL COMPOUNDS AS ANTAGONISTS OR INVERSE AGONISTS AT OPIOID RECEPTORS SMITHKLINE BEECHAM CORPORATION (US) 2008-02-21 WO disclosed